Searched over 200M research papers
6 papers analyzed
Some studies suggest that side effects of losartan go away after discontinuing the drug, while other studies indicate it is generally well-tolerated with minimal side effects.
20 papers analyzed
Losartan is a widely used antihypertensive medication that functions as an angiotensin II receptor antagonist. It is primarily prescribed to manage high blood pressure and protect against hypertension-related complications such as cardiovascular injury and proteinuria. Despite its efficacy, patients and healthcare providers often question whether the side effects associated with losartan diminish over time.
Clinical trials have identified several common side effects of losartan, including headache, upper respiratory tract infection, dizziness, and fatigue . These side effects are generally mild and occur at a similar frequency to those experienced by patients taking a placebo. Notably, dizziness is the only side effect reported more frequently in losartan-treated patients compared to those on placebo .
Long-term studies have shown that losartan is well-tolerated by most patients. In trials involving approximately 2,900 hypertensive patients, the incidence of adverse events was comparable between losartan and placebo groups . Additionally, losartan has been found to be metabolically neutral, with no significant adverse effects on glucose and lipid metabolism. This makes it a suitable option for patients with concomitant conditions such as diabetes, renal impairment, or heart failure.
While losartan is generally safe, there have been rare reports of serious side effects. For instance, two patients experienced marked hepatotoxicity, indicated by significant increases in liver enzymes, which resolved after discontinuing the medication. This suggests that some serious side effects may subside once the drug is stopped.
In patients with renal transplants, losartan has been shown to effectively lower blood pressure and reduce proteinuria without adversely affecting graft function. The major side effect observed in this group was a reduction in hemoglobin levels, which was significant but manageable.
Interestingly, losartan has also been studied in combination with other medications. For example, when combined with axitinib, a potent VEGF receptor inhibitor, losartan significantly reduced the blood pressure rise caused by axitinib without compromising its antitumor efficacy. This indicates that losartan can be used to mitigate side effects from other treatments, enhancing overall patient tolerability.
In summary, the side effects of losartan are generally mild and comparable to those of a placebo. Long-term use of losartan is well-tolerated, and serious side effects are rare and often reversible upon discontinuation of the drug. For patients experiencing mild side effects, these may diminish over time as the body adjusts to the medication. However, any serious adverse effects should be promptly addressed by discontinuing the drug and consulting a healthcare provider.
Most relevant research papers on this topic